(Boursier.com) — Median Technologies will speak at the ESMO 2022 Oncology Congress, September 9-13 in Paris, with two presentations regarding its iCRO services for image management in oncology clinical trials and its iBiopsy medical device software.
On September 10, the company will present the scientific poster “Challenges to Assess Bone Metastases in Blinded Independent Central Review (BICR) of Breast Cancer Trials Using RECIST 1.1”. On September 11, the presentation is titled “Artificial Intelligence Supporting Lung Cancer Screening: Computer Aided Diagnosis of Lung Lesions Driven by Morphological Feature Extraction”.
©2022 Boursier.com